Figure 7From: Molecular mechanisms of action and potential biomarkers of growth inhibition of dasatinib (BMS-354825) on hepatocellular carcinoma cells Effect of dasatinib on PLC/PRF/6 cell signaling. Total Src and p-Src, p-EGFR expression after dasatinib treatment in PLC/PRF/6 cell line were shown. P-Src/t-Src was quantified by ImageJ software. * p < 0.05 as compared with the control (student’s t-test).Back to article page